Specialty Medical Equipment in Massachusetts
5 vendors serving Massachusetts
Find specialty medical equipment vendors in Massachusetts. MedIndexer lists vendors headquartered in Massachusetts alongside nationwide vendors that serve Massachusetts. Compare profiles, review service areas, and contact vendors directly — no middleman, no fees for buyers.
Top specialty medical equipment in Massachusetts
MTD Micro Molding
MTD Micro Molding is an FDA-registered, ISO 13485:2016-certified single-source manufacturer specializing in precision micro-molded medical device components and minimally invasive medical/healthtech devices. The company delivers custom injection-molded parts with ultra-tight tolerances (down to 0.02mm and 0.004" wall thicknesses) for complex applications including overmolded electrodes, bioabsorbable implants, PEEK biopsy markers, ablation catheter tips, ENT implants, and vascular devices. MTD's integrated design-for-manufacturability (DFM) approach combines material selection, tooling design, precision molding, and packaging under one roof to reduce iterations and unit costs. The company employs custom carbide tooling, diamond-turned inserts, and advanced metrology capabilities (including optical 3D measurement systems) to achieve critical dimensional and functional requirements. Capabilities include multi-gate systems with minimal vestige, overmolding of electrodes and other sensitive components, and production of bioabsorbable and specialty polymer devices. MTD serves medtech device developers and OEMs requiring validated, high-precision manufacturing for minimally invasive surgical instruments, implants, and diagnostic devices. The company emphasizes early-stage engineering collaboration and has established credentials in the micro medical device manufacturing sector.
Neuroelectrics Barcelona S.L.U.
Neuroelectrics develops a cloud-based, personalized neuromodulation platform (Starstim) for treating brain disorders including refractory focal epilepsy and treatment-resistant depression. The platform integrates three modular components: a multi-channel transcranial electrical stimulation (tES) headpiece for EEG monitoring and neuromodulation, cloud-based secure remote treatment delivery, and AI-driven personalization based on computational neuroscience, data science, and patient physiological data. The company's approach targets dysfunctional neural circuits holistically rather than single brain nodes, offering a non-invasive, non-drug therapeutic option for patients unresponsive to pharmacological or surgical interventions. Starstim hardware and research tools are widely used in neuroscience research, with hundreds of published papers utilizing the platform. The company is conducting pivotal clinical trials in refractory focal epilepsy (NCT04770337) and pilot studies in at-home depression treatment (NCT05205915). Neuroelectrics serves both clinical therapeutic and research markets, with regulatory clearance for investigational use in multiple jurisdictions.
Insulet Corporation
Insulet Corporation, headquartered in Acton, Massachusetts, is a global medical device manufacturer specializing in insulin delivery systems. The company is the maker of Omnipod, a line of tubeless, wearable, Pod-based insulin management systems designed to eliminate multiple daily injections for people with diabetes. Omnipod systems provide continuous insulin delivery through waterproof (IP28 rated), connected pods with integrated glucose monitoring and automated insulin delivery capabilities. The Omnipod 5 system is the #1 U.S. requested and prescribed Automated Insulin Dosing (AID) system as of 2025. Insulet serves over 600,000 global customers across 25 countries, with 2025 revenue of $2.7 billion. The company maintains manufacturing and office facilities worldwide and operates with a focus on regulatory compliance and innovation in diabetes management. Insulet is publicly traded on NASDAQ under ticker PODD and demonstrates commitment to sustainability and responsible growth. The company's product development is driven by extensive research and development focused on simplifying diabetes management for patients. Omnipod devices feature tubeless design, waterproofing for practical daily use, and integration with continuous glucose monitoring systems.
Braintree Scientific, Inc.
Braintree Scientific, Inc. provides research equipment and support for medical researchers
MYOMO, INC.
Myomo, Inc. manufactures the MyoPro®, an electronically controlled orthotic brace designed to restore functional arm and hand movement in patients with upper-limb paralysis. The device is indicated for individuals with stroke, brachial plexus injury (BPI), cerebral palsy, and other neuromuscular diseases or injuries. The MyoPro uses surface electromyography (sEMG) technology to detect residual muscle signals and trigger controlled electrical stimulation, enabling users to perform functional activities during therapy and in home settings. The company markets to both clinical rehabilitation providers and individual patients. Myomo has achieved Medicare reimbursement under DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) fee schedules, with CPT codes L8701 and L8702 established as of April 2024. The device is custom-fabricated for individual patients and is used primarily in stroke recovery, brachial plexus injury treatment, and veteran rehabilitation programs. The company emphasizes improved activities of daily living (ADL) outcomes and quality-of-life restoration. Myomo supports clinical education through webinars for clinicians, providers, and industry partners. The MyoPro represents a non-invasive, wearable neuroprosthetic approach to upper-limb rehabilitation, combining orthotic support with functional electrical stimulation technology.